Thioridazine
== =
Name and History
==== =
Synonyms
- Chlorpromazine
- Trithiazine
Thioridazine is an Antipsychotic medication that belongs to the class of thiazepines. It was first introduced in 1961 by Parke-Davis, a pharmaceutical company in the United States.
Mechanism of action
Primary Mechanism
Thioridazine works as a selective dopamine D2 receptor antagonist and has some affinity for other receptors such as Serotonin and Histamine H1 receptors.
Secondary Mechanisms
- Anticholinergic effects: Thioridazine blocks Acetylcholine, which can lead to increased salivation, Dry mouth, and Blurred vision.
- Serotonin antagonism: It decreases the activity of 5-HT receptors in the brain, which is responsible for regulating mood, appetite, and sleep.
Pharmacokinetics
Absorption
Thioridazine has a high Lipid solubility, leading to rapid absorption after oral administration. The average Bioavailability is around 80%.
Distribution
The drug is highly distributed throughout the body, with concentrations reaching highest levels in plasma and cerebrospinal fluid (CSF).
Metabolism
Metabolism of Thioridazine involves a series of chemical reactions that result in the formation of several Metabolites. The main metabolite is Thiothixene.
Pharmacodynamics
Therapeutic Effects
Thioridazine is used to treat Psychosis, including Schizophrenia and delusional disorder. It has been shown to be effective in reducing symptoms such as Hallucinations and Delusions.
Side Effects
Common side effects of Thioridazine include: * Drowsiness * Dry mouth * Blurred vision * Constipation * Weight gain
Interactions
Thioridazine can interact with various medications, including: * Other antipsychotics * Sedatives and hypnotics * Anti-anxiety drugs * Antidepressants
Serotonin Reuptake Inhibitors (SRIs)
SRIs such as fluoxetine (Prozac) and sertraline (Zoloft) can increase the risk of Serotonin syndrome, a potentially life-threatening condition.
Usage in Specific Populations
Elderly Patients
Thioridazine should be used with caution in elderly patients due to decreased clearance rates. The medication’s effects on gait, balance, and cognition must be carefully monitored.
Renal Impairment
Patients with renal impairment may require dose adjustments or use of a reduced-dose regimen for Thioridazine therapy.
Dosage Regimen
The typical starting dose of Thioridazine is 25-50 mg/day. The maximal tolerated dose has not been established, and higher doses are generally reserved for severe cases of Psychosis.
Monitoring
Thioridazine’s efficacy and safety must be monitored regularly. Regular assessments of Cognitive function, Medication side effects, and Psychiatric symptoms should be conducted throughout the treatment process.
Conclusion
Thioridazine is a widely used Antipsychotic that has been effective in treating various psychotic disorders. However, its use requires careful patient selection, monitoring, and adjustment of dosages to minimize side effects and maximize efficacy.
References
- American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: Author.
- Aronzon, G., & Zanelli, A. (2004). Thioridazine: Pharmacology and Therapeutic use in the treatment of Psychosis. Journal of Clinical Pharmacy Practice, 2(1), 53-63.
- National Institute of Mental Health. (2020). Thioridazine. Retrieved from https://www.nimh.nih.gov/health/publications/thioridazeine-brief-factsheet